FOR US HEALTHCARE PROFESSIONALS ONLY
For adults living with schizophrenia
Repeated relapses and cycles of failure on oral antipsychotics can shatter lives
SYMPTOM STABILITY
CAN’T WAIT
See how INVEGA SUSTENNA® can provide patients
with superior symptom control today
Help avoid cycles of repeated relapses associated with daily orals. Prescribe INVEGA SUSTENNA®—the #1 prescribed long-acting injectable.1
Evaluated vs placebo and compared to groups of oral antipsychotics
Evaluated in over 2,500 patients across 7 trials
Initiate, maintain, and adjust dosing—and how to transition patients to INVEGA SUSTENNA®
Transitioning from other antipsychotics
A step-by-step guide for preparing and administering INVEGA SUSTENNA®
In a survey of adults with schizophrenia currently taking a long-acting injectable (LAI)
90%
wished they would have started it sooner, now knowing what it’s like to live with schizophrenia.1*
*Based on results from a survey of randomly selected adult patients with schizophrenia (N=200). A subgroup of patients were current LAI users (n=49), and among those users, 90% (n=44/49) agreed strongly, mostly, or somewhat (on a 7-point scale) that they wished they would have started a long-acting injectable treatment sooner after their diagnosis.1
Reference: 1. Data on file. Janssen Pharmaceuticals, Inc.